|
Prevalence of ARID1A Mutations in Cell-Free Circulating Tumor DNA in a Cohort of 71,301 Patients and Association with Driver Co-Alterations
|
September 9, 2022
|
PC3I Authors Charu Aggarwal |
Cancers (Basel)
|
|
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
|
August 11, 2022
|
PC3I Authors Charu Aggarwal |
JCO Precision Oncology
|
|
Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapy
|
June 15, 2022
|
PC3I Authors Charu Aggarwal |
Scientific Reports
|
|
Aumolertinib in EGFR-Mutant Lung Cancer: Will the Promise of Cost Disruption Ease Access?
|
June 9, 2022
|
PC3I Authors Charu Aggarwal |
Journal of Clinical Oncology
|
|
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma
|
May 31, 2022
|
PC3I Authors Charu Aggarwal |
Journal for Immunotherapy of Cancer
|
|
COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer
|
April 22, 2022
|
PC3I Authors Charu Aggarwal |
Journal of Clinical Oncology
|
|
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial
|
April 13, 2022
|
PC3I Authors Charu Aggarwal |
Journal for Immunotherapy of Cancer
|
|
Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot Study
|
April 8, 2022
|
PC3I Authors Charu Aggarwal; Melina Marmarelis; Christopher A. D’Avella; Anil Vachani |
JTO Clinical and Research Reports
|
|
Phase II Trial of Combination Nab-paclitaxel and Gemcitabine in Non-squamous Non-small Cell Lung Cancer After Progression on Platinum and Pemetrexed
|
April 8, 2022
|
PC3I Authors Charu Aggarwal; Melina Marmarelis; Christopher A. D’Avella |
Clinical Lung Cancer
|
|
A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers
|
March 4, 2022
|
PC3I Authors Charu Aggarwal |
Oral Oncology
|
|
Platinum Re-Exposure as a Non-Small Cell Lung Cancer (NSCLC) Treatment Strategy in the Age of Immunotherapy
|
January 30, 2022
|
PC3I Authors Melina Marmarelis; Ronac Mamtani; Charu Aggarwal |
Clinical Lung Cancer
|
|
Impact of Interobserver Variability in Manual Segmentation of Non-Small Cell Lung Cancer (NSCLC) Applying Low-Rank Radiomic Representation on Computed Tomography
|
December 10, 2021
|
PC3I Authors Charu Aggarwal |
Cancers
|
|
Molecular testing in stage I-III non-small cell lung cancer: Approaches and challenges
|
November 5, 2021
|
PC3I Authors Charu Aggarwal |
Lung Cancer
|
|
Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO Registry
|
October 25, 2021
|
PC3I Authors Charu Aggarwal |
JCO Oncology Practice
|
|
Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic
|
October 12, 2021
|
PC3I Authors Charu Aggarwal; Peter Gabriel; Larry Shulman; Melina Marmarelis |
BMC Cancer
|
|
Optimization of Sources of Circulating Cell-Free DNA Variability for Downstream Molecular Analysis
|
August 28, 2021
|
PC3I Authors Charu Aggarwal |
Journal of Molecular Diagnostics
|
|
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
|
July 11, 2021
|
PC3I Authors Charu Aggarwal |
Journal of Thoracic Oncology
|
|
Immunotherapy for Head and Neck Cancer
|
July 10, 2021
|
PC3I Authors Charu Aggarwal |
Hematology/Oncology Clinics of North America
|
|
Plasma Cell-Free DNA Genotyping: From an Emerging Concept to a Standard-of-Care Tool in Metastatic Non-Small Cell Lung Cancer
|
July 3, 2021
|
PC3I Authors Charu Aggarwal |
The Oncologist
|
|
Survival and toxicity in patients with human papilloma virus-associated oropharyngeal squamous cell cancer receiving trimodality therapy including transoral robotic surgery
|
June 25, 2021
|
PC3I Authors Charu Aggarwal |
Head & Neck
|
